Bernhard Zimmermann is a Sr. Executive Research Fellow at Natera, specializing in cfDNA testing for oncology and transplant monitoring. Educated at ETH Zürich and the University of Basel, he is a prolific inventor with over 100 granted patents and led the development of key diagnostic products like Signatera and Prospera.
Beyond his scientific contributions, Bernhard finds deep personal motivation in helping people with cancer and failing organs. He is also a supporter of the Athletes Network, indicating an interest in sports and athlete development, and actively engages with the scientific community by attending conferences like ESMO.
He is the main inventor of massively multiplex PCR targeted sequencing, a foundational technology he guided from inception to commercial launch.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.